Dr. Roni Tamari, MD
Claim this profileMemorial Sloan Kettering Cancer Center
Area of expertise
Acute Myelogenous Leukemia
Roni Tamari, MD has run 4 trials for Acute Myelogenous Leukemia. Some of their research focus areas include:
Acute Myeloid Leukemia
Roni Tamari, MD has run 4 trials for Acute Myeloid Leukemia. Some of their research focus areas include:
Affiliated Hospitals
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Monmouth (Limited Protocol Activities)
Clinical Trials Roni Tamari, MD is currently running
Azacitidine + Venetoclax vs Stem Cell Transplant
for Acute Myeloid Leukemia
The researchers are doing this study to find out if an allogeneic hematopoietic stem cell transplant (HSCT) or maintenance therapy with azacitidine and venetoclax is more effective at keeping AML from coming back (relapsing).
Recruiting
1 award
Phase 2
5 criteria
Stem Cell Transplantation
for Acute Leukemia
The investigators are doing this research study to assess the percentage of patients receiving stem cell transplantation for the type of blood cancer you have. They want to know how many patients get a transplant and why some patients do get a transplant while others do not. Also they want to explore why some patients elect not to undergo stem cell transplantation, when it is recommended by their physicians.
Recruiting
1 award
N/A
10 criteria
More about Roni Tamari, MD
Clinical Trial Related
7 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Roni Tamari, MD has experience with
- Allogeneic Hematopoietic Stem Cell Transplantation
- Orca-T
- Plerixafor
- Ruxolitinib
- Fludarabine
- Busulfan
Breakdown of trials Roni Tamari, MD has run
Acute Myelogenous Leukemia
Acute Myeloid Leukemia
Acute Leukemia
Myelodysplastic Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Roni Tamari, MD specialize in?
Roni Tamari, MD focuses on Acute Myelogenous Leukemia and Acute Myeloid Leukemia. In particular, much of their work with Acute Myelogenous Leukemia has involved CD33 positive patients, or patients who are HLA-A positive.
Is Roni Tamari, MD currently recruiting for clinical trials?
Yes, Roni Tamari, MD is currently recruiting for 2 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Roni Tamari, MD has studied deeply?
Yes, Roni Tamari, MD has studied treatments such as Allogeneic Hematopoietic Stem Cell Transplantation, Orca-T, Plerixafor.
What is the best way to schedule an appointment with Roni Tamari, MD?
Apply for one of the trials that Roni Tamari, MD is conducting.
What is the office address of Roni Tamari, MD?
The office of Roni Tamari, MD is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.